文献速递头颈部肿瘤放疗

儿童鼻咽癌:一种具有独特特征且预后良好的罕见疾病

Childhood Nasopharyngeal Carcinoma: A Rare Disease With Distinct Features and Favorable Prognosis.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-04-15

该回顾性研究比较了140例儿童鼻咽癌(<21岁)与280例倾向评分匹配的成人患者,儿童组分期更晚但5年OS(83.1% vs 71.9%,P=.001)和PFS(71.6% vs 60.9%,P=.023)更高,局部区域复发率更低(3.1% vs 12.6%,P=.002)。儿童放射敏感性高,诱导化疗无反应者仍可获得高局部控制,支持个体化治疗。

要点

  • 儿童鼻咽癌分期更晚但5年OS和PFS显著优于成人。
  • 儿童局部区域复发率显著低于成人(3.1% vs 12.6%)。
  • 儿童放射敏感性高,诱导化疗无反应者仍可获高局部控制。

核心结论

  • 儿童鼻咽癌常分期较晚但预后良好,局部区域控制极佳,放射敏感性高可能允许降低剂量。

主要发现

  • 儿童组5年OS为83.1% vs 成人71.9%(P=.001),5年PFS为71.6% vs 60.9%(P=.023),局部区域复发率为3.1% vs 12.6%(P=.002)。
  • 儿童接受诱导化疗后,完全/部分缓解与稳定/进展患者在OS(84.0% vs 75.7%,P=.289)、PFS(75.2% vs 57.7%,P=.123)、LRR(4.4% vs 3.8%,P=.656)和远处转移(22.4% vs 38.5%,P=.122)上无显著差异。
  • 儿童2年后晚期复发较少(13.6% vs 29.2%,P=.039),且更高比例成功挽救治疗(42.1% vs 21.7%,P=.015)。

临床怎么用

  • 儿童鼻咽癌治疗可考虑根据高放射敏感性个体化调整剂量,并关注晚期毒性。
  • 诱导化疗反应不佳的儿童仍可能通过放疗获得良好局部控制,不应轻易放弃根治性放疗。
  • 儿童患者需长期随访以监测晚期复发和远期不良反应。

局限性

  • 单中心回顾性研究,样本量有限,结论需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to compare clinical features, treatment responses, radiosensitivity, and failure patterns between childhood and adult nasopharyngeal carcinoma (NPC) patients in the era of intensity modulated radiation therapy. METHODS AND MATERIALS: A retrospective review was conducted on 140 childhood NPC patients, aged <21 years, treated at a single institution between January 2004 and November 2019. A propensity score matching method was used to select 280 matched adult NPC patients in a 1:2 ratio. Comparative analysis was performed between the childhood and adult cohorts. RESULTS: Childhood NPC is associated with more advanced clinical stages, heightened radiosensitivity, and improved prognostic outcomes compared to adult NPC. The 5-year rates for overall survival (OS), progression-free survival (PFS) were significantly higher in the childhood group compared with the adult group: 83.1% versus 71.9% (P = .001) for OS, 71.6% versus 60.9% (P = .023) for PFS, but significantly lower for locoregional relapse (LRR): 3.1% versus 12.6% (P = .002). Childhood NPC exhibited heightened radiosensitivity, and high locoregional control can be achieved even in cases that showed no response to induction chemotherapy, which is unlike in adults. In children receiving induction chemotherapy, no significant differences were found in OS (84.0% vs 75.7%, P = .289), PFS (75.2% vs 57.7%, P = .123), LRR (4.4% vs 3.8%, P = .656), and distant metastasis (22.4% vs 38.5%, P = .122) between those with complete/partial response and those with stable/progression disease. Late recurrence after 2 years was less frequent in children than in adults (13.6% vs 29.2%, P = .039), and a higher proportion of childhood patients were successfully salvaged (42.1% vs 21.7%, P = .015). CONCLUSIONS: Childhood NPC often presents at an advanced stage but has a favorable prognosis with excellent locoregional control. Children's heightened radiosensitivity allows for potential dose reduction. Given the risk of late effects, individualized treatment and follow-up strategies are warranted for young patients.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Sun S, Huang X, Liu Y, et al. Childhood Nasopharyngeal Carcinoma: A Rare Disease With Distinct Features and Favorable Prognosis. Int J Radiat Oncol Biol Phys. 2026. PMID: 41990887. doi:10.1016/j.ijrobp.2026.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。